clinical trials

Recap Results Trial description old Pinterest treatment Z

Cardiovascular prevention

All chronical situations: 6 trials - CDP estrogen 2.5 - CDP estrogen 5 - VA drugs (Estrogen or thyroxine) - VA Neurology Section (estrogen) - Stamler - Marmorstein

All type of patients: 17 trials - WISDOM - EAGAR - WHISP - WELL-HART (estrogen alone) - WELL-HART (estrogen-progestin) - ESPRIT - Schulman (NHLBI) (estrogen alone) - Schulman (NHLBI) (estrogen-progestogen) - WAVE - WHI - EPAT - WEST - ERA (estrogen alone ) - ERA (estrogen plus medroxyprogesterone) - EVTET - Hall - HERS

Patients with other atherosclerotic localisation: 1 trials - VA Neurology Section (estrogen)

Patients with prior MI or with CHD: 5 trials - CDP estrogen 2.5 - CDP estrogen 5 - VA drugs (Estrogen or thyroxine) - Stamler - Marmorstein

Primary prevention: 2 trials - WHI - EPAT

Secondary prevention: 13 trials - EAGAR - WHISP - WELL-HART (estrogen alone) - WELL-HART (estrogen-progestin) - ESPRIT - Schulman (NHLBI) (estrogen alone) - Schulman (NHLBI) (estrogen-progestogen) - WAVE - ERA (estrogen alone ) - ERA (estrogen plus medroxyprogesterone) - EVTET - Hall - HERS